Medical Countermeasures Chikungunya Vaccine Candidate Granted Accelerated Review by EMAGlobal Biodefense StaffFebruary 23, 2024
Biodetection NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and FluGlobal Biodefense StaffFebruary 1, 2024
Medical Countermeasures Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UKGlobal Biodefense StaffJanuary 24, 2024
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
Inflammatix Completes Development for Acute Infection and Sepsis Test System Biodetection November 15, 2023 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance Biodetection September 19, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
RedHill Biopharma Highlights Federal Medical Countermeasure Investments Industry News August 17, 2023 …
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel Biodetection August 1, 2023 …
908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection Biodetection July 31, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …